top
Search terms
Results 1 - 10 of 10 - ordered by :
Ehjournal

Risk factors were age over 65 years, male gender [hazard ratio (HR) 1.2], previous MI (HR 1.5), previous stroke and/or peripheral vascular disease (HR 1.7), diabetes, smoking, angina (all HR 1.5), ...

European Heart Journal, Deckers, Jaap W., Goedhart, Dick M., Boersma, Eric, Briggs, Andrew, Bertrand, Michel, Ferrari, Roberto, Remme, Willem J., Fox, Kim, Simoons, Maarten L.

Date : 01/04/2006 Item size : 176909 bytes
Ehjournal

Remaining need On the other hand, such hesitation or even avoidance to invest in cardiovascular research and development is not acceptable for the scientific community as cardiovascular mortality, ...

European Heart Journal, Ferrari, Roberto, Lüscher, Thomas F.

Date : 01/09/2016
Ehjournal

Risk factors were age over 65 years, male gender [hazard ratio (HR) 1.2], previous MI (HR 1.5), previous stroke and/or peripheral vascular disease (HR 1.7), diabetes, smoking, angina (all HR 1.5), ...

European Heart Journal, Deckers, Jaap W., Goedhart, Dick M., Boersma, Eric, Briggs, Andrew, Bertrand, Michel, Ferrari, Roberto, Remme, Willem J., Fox, Kim, Simoons, Maarten L.

Date : 01/04/2006 Item size : 191784 bytes
Ehjcardiovascrec

The results of the HOPE (Heart Outcomes Prevention Evaluation) trial caused much excitement when they were announced in 2000;3 HOPE was the first study to investigate the effects of ACE inhibition in ...

Cardiovascular Research, Ferrari, Roberto, Ceconi, Claudio

Date : 01/11/2012 Item size : 143849 bytes
Ehjcardiovascrec

Abstract Objectives: EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease [EUROPA] demonstrates reduction in cardiovascular mortality and myocardial ...

Cardiovascular Research, Ceconi, Claudio, Fox, Kim M., Remme, William J., Simoons, Marteen L., Bertrand, Michael, Parrinello, Giovanni, Kluft, Cornelius, Blann, Andrew, Cokkinos, Dennis, Ferrari, ...

Date : 01/01/2007 Item size : 297030 bytes
Ehjournal

Abstract Aims The aim of this study was to assess the effect of the angiotensin converting enzyme inhibitor perindopril on cardiovascular events in diabetic patients with coronary artery ...

European Heart Journal, Daly, Caroline A., Fox, Kim M., Remme, Willem J., Bertrand, Michel E., Ferrari, Roberto, Simoons, Maarten L.

Date : 01/07/2005
Ehjcardiovascrec

Abstract Objectives: EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease [EUROPA] demonstrates reduction in cardiovascular mortality and myocardial ...

Cardiovascular Research, Ceconi, Claudio, Fox, Kim M., Remme, William J., Simoons, Marteen L., Bertrand, Michael, Parrinello, Giovanni, Kluft, Cornelius, Blann, Andrew, Cokkinos, Dennis, Ferrari, ...

Date : 01/01/2007 Item size : 297419 bytes
Ehjcardiovascrec

The results of the HOPE (Heart Outcomes Prevention Evaluation) trial caused much excitement when they were announced in 2000;3 HOPE was the first study to investigate the effects of ACE inhibition in ...

Cardiovascular Research, Ferrari, Roberto, Ceconi, Claudio

Date : 01/11/2012 Item size : 147765 bytes
Ehjournal

Remaining need On the other hand, such hesitation or even avoidance to invest in cardiovascular research and development is not acceptable for the scientific community as cardiovascular mortality, ...

European Heart Journal, Ferrari, Roberto, Lüscher, Thomas F.

Date : 01/09/2016 Item size : 286234 bytes
Ehjournal

Abstract Aims The 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline on high blood pressure (BP) lowered the threshold defining hypertension and BP target in high-risk ...

European Heart Journal, Vidal-Petiot, Emmanuelle, Sorbets, Emmanuel, Bhatt, Deepak L, Ducrocq, Gregory, Elbez, Yedid, Ferrari, Roberto, Ford, Ian, Tardif, Jean-Claude, Tendera, Michal, Fox, Kim M, ...

Date : 14/11/2018 Item size : 347191 bytes